Dana Simmons wants you to know that if you are hungry, it is not your fault. In her recently released book, “On Hunger: ...

The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...

Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...

During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

Diving into the complexities of sustainability in healthcare packaging that include circular economy strategies, takeback ...

Sogroya (somapacitan injection) has been recommended by UK health technology assessor the National Institute for Health and ...